Antimicrobial peptides as new tools to combat infectious diseases

被引:10
|
作者
Sebok, Csilla [1 ]
Marton Rege, Anna [1 ]
Mackei, Mate [1 ]
Neogrady, Zsuzsanna [1 ]
Matis, Gabor [1 ]
机构
[1] Allatorvostud Egyet, Elettani & Biokemiai Tanszek, Istvan Utca 2, H-1078 Budapest, Hungary
关键词
HOST-DEFENSE PEPTIDES; BACTERICIDAL SUBSTANCES; RED PROTEIN; MEMBRANE; LL-37; ANTIBACTERIAL; MECHANISM; SKIN; PURIFICATION; MODULATION;
D O I
10.56385/magyallorv.2024.03.181-191
中图分类号
S85 [动物医学(兽医学)];
学科分类号
0906 ;
摘要
The rapidly growing rates of antimicrobial resistance represent a great challenge not just in human, but in veterinary medicine, as well. The restriction of antibiotic usage and the increasing spread of resistance made preventing and treating bacterial infections increasingly difficult. Therefore, research into compounds that can be used as substitutes for antibiotics is of particular importance. Antimicrobial Peptides (AMPs), also known as Host Defense Peptides (HDPs) can be considered promising candidates in this respect. They are small, typically cationic peptides of up to 100 amino acids, have a diverse structure and are produced in almost all living organisms as part of innate immunity. In this review article, the authors describe the direct antibacterial activity of AMPs, which is based on their cationic and amphipathic structures. They are able to bind to the mostly negatively charged bacterial membrane and produce pores with several different mechanisms. The disrupted permeability is often enough to kill the microbe; however, AMPs can also bind to several intracellular targets, such as the DNA, and they can inhibit protein or nucleic acid synthesis. Moreover, the authors explain the extensive immunomodulatory activity of these peptides, which enables them to recruit and activate immune cells, modulate cytokine and chemokine release, promote wound healing and angiogenesis, and decrease harmful inflammatory processes. Nowadays attention tends to shift to these fatter as higher AMP concentrations are needed to achieve a direct antibacterial effect in vivo because of the high level of salts and glycosaminoglycans. In contrast, they can provide effective protection against infectious agents and harmful inflammatory processes through their indirect immunomodulatory effects even at Power concentrations. It is therefore essential to conduct research on AMPs as alternative agents against bacterial infections to determine which therapeutic candidates will be most applicable and useful in the future.
引用
收藏
页码:181 / 191
页数:11
相关论文
共 50 条
  • [1] Peptides to combat viral infectious diseases
    Al-Azzam, Shams
    Ding, Yun
    Liu, Jinsha
    Pandya, Priyanka
    Ting, Joey Paolo
    Afshar, Sepideh
    PEPTIDES, 2020, 134
  • [2] Reprogramming biological peptides to combat infectious diseases
    Der Torossian Torres, Marcelo
    de la Fuente-Nunez, Cesar
    CHEMICAL COMMUNICATIONS, 2019, 55 (100) : 15020 - 15032
  • [3] Drug Delivery Systems for the Oral Administration of Antimicrobial Peptides: Promising Tools to Treat Infectious Diseases
    Deshayes, Caroline
    Arafath, Md. Nasir
    Apaire-Marchais, Veronique
    Roger, Emilie
    FRONTIERS IN MEDICAL TECHNOLOGY, 2022, 3
  • [4] Rapid diagnostics for infectious diseases: a solution to combat antimicrobial resistance
    Patel, Robin
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2017, 50 : S59 - S59
  • [5] Modified phages: Novel antimicrobial agents to combat infectious diseases
    Moradpour, Zahra
    Ghasemian, Abdollah
    BIOTECHNOLOGY ADVANCES, 2011, 29 (06) : 732 - 738
  • [6] Editorial: Peptides against infectious diseases: from antimicrobial peptides to vaccines
    Bojarska, Joanna
    Wang, Xiumin
    Skwarczynski, Mariusz
    FRONTIERS IN PHARMACOLOGY, 2024, 15
  • [7] Antimicrobial peptides in the innate immunity of infectious diseases.
    Rivas-Santiago, B
    Sada, E
    Hernández-Pando, R
    Tsutsumi, V
    SALUD PUBLICA DE MEXICO, 2006, 48 (01): : 62 - 71
  • [8] Antimicrobial peptides, a promising alternative for the treatment of infectious diseases
    Olascoaga-Del Angel, Kevin Samael
    Sanchez-Evangelista, Grecia
    Carmona-Navarrete, Israel
    del Carmen Galicia-Sanchez, Maria
    Gomez-Luna, Angelica
    Janneth Islas-Arrollo, Susan
    Ismael Castaneda-Sanchez, Jorge
    GACETA MEDICA DE MEXICO, 2018, 154 (06): : 681 - 688
  • [9] Antimicrobial Peptides in Infectious Diseases and Beyond-A Narrative Review
    Ioannou, Petros
    Baliou, Stella
    Kofteridis, Diamantis P.
    LIFE-BASEL, 2023, 13 (08):
  • [10] New and old tools to evaluate new antimicrobial peptides
    Rudilla, Hector
    Merlos, Alexandra
    Sans-Serramitjana, Eulalia
    Fuste, Ester
    Sierra, Josep M.
    Zalacain, Antonio
    Vinuesa, Teresa
    Vinas, Miguel
    AIMS MICROBIOLOGY, 2018, 4 (03): : 522 - 540